LOX Index, a Novel Predictive Biochemical Marker for Coronary Heart Disease and Stroke
Open Access
- 1 April 2010
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 56 (4) , 550-558
Abstract
Background: Lectin-like oxidized LDL receptor 1 (LOX-1) is implicated in atherothrombotic diseases. Activation of LOX-1 in humans can be evaluated by use of the LOX index, obtained by multiplying the circulating concentration of LOX-1 ligands containing apolipoprotein B (LAB) times that of the soluble form of LOX-1 (sLOX-1) [LOX index = LAB × sLOX-1]. This study aimed to establish the prognostic value of the LOX index for coronary heart disease (CHD) and stroke in a community-based cohort. Methods: An 11-year cohort study of 2437 residents age 30–79 years was performed in an urban area located in Japan. Of these, we included in the analysis 1094 men and 1201 women without history of stroke and CHD. We measured LAB and sLOX-1 using ELISAs with recombinant LOX-1 and monoclonal anti–apolipoprotein B antibody and with 2 monoclonal antibodies against LOX-1, respectively. Results: During the follow-up period, there were 68 incident cases of CHD and 91 cases of stroke (with 60 ischemic strokes). Compared with the bottom quartile, the hazard ratio (HR) of the top quartile of LOX index was 1.74 (95% CI 0.92–3.30) for stroke and 2.09 (1.00–4.35) for CHD after adjusting for sex, age, body mass index, drinking, smoking, hypertension, diabetes, non-HDL cholesterol, and use of lipid-lowering agents. Compared with the bottom quartile of LOX index, the fully adjusted HRs for ischemic stroke were consistently high from the second to the top quartile: 3.39 (95% CI 1.34–8.53), 3.15 (1.22–8.13) and 3.23 (1.24–8.37), respectively. Conclusions: Higher LOX index values were associated with an increased risk of CHD. Low LOX index values may be protective against ischemic stroke.Keywords
Funding Information
- Ministry of Health, Labour and Welfare
- National Institute of Biomedical Innovation
- Japan Science and Technology Agency
- New Energy and Industrial Technology Development Organization
This publication has 37 references indexed in Scilit:
- Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita studyAtherosclerosis, 2009
- LOX-1 The Multifunctional Receptor Underlying Cardiovascular DysfunctionCirculation Journal, 2009
- Association Between Circulating Oxidized Low-Density Lipoprotein and Incidence of the Metabolic SyndromeJAMA, 2008
- Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deathsThe Lancet, 2007
- Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Circulating Oxidized Low Density Lipoprotein LevelsArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Malondialdehyde-Modified LDL as a Marker of Acute Coronary SyndromesJAMA, 1999
- An endothelial receptor for oxidized low-density lipoproteinNature, 1997
- High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men.Circulation, 1994